4.0
Jul 10, 2013
Recommend
CEO approval
Business Outlook
Pros
Good r&d processes with an emphasis on science HR is getting better - becoming more employee focused They have a promising pipeline
Cons
Very top heavy structure. Decisions are often slow, diluted and poorly communicated. Progression not always possible Most major pharma companies acquiring vaccines - there is incresing competition